NET PROFIT (x1000 NOK)
EMPLOYEES
Vicore Pharma Holding AB
Closing information (x1000 NOK)
Closing information | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Turnover | 0 | 0 | 0 |
Financial expenses | 450 | 2,499 | 6 |
Earnings before taxes | -273,185 | -289,383 | -154,327 |
EBITDA | -271,825 | -284,004 | |
Total assets | 319,725 | 439,989 | 425,866 |
Current assets | 255,198 | 368,567 | 343,453 |
Current liabilities | 43,788 | 63,945 | 46,402 |
Equity capital | 273,447 | 373,818 | 371,388 |
- share capital | 38,711 | 34,991 | 26,281 |
Employees (average) | 21 | 16 | 13 |
Financial ratios
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Solvency | 85.5% | 85.0% | 87.2% |
Turnover per employee | 0 | 0 | 0 |
Profit as a percentage of turnover | |||
Return on assets (ROA) | -85.3% | -65.2% | -36.2% |
Current ratio | 582.8% | 576.4% | 740.2% |
Return on equity (ROE) | -99.9% | -77.4% | -41.6% |
Change turnover | 0 | 0 | 0 |
Change turnover % | |||
Chg. No. of employees | 5 | 3 | 5 |
Chg. No. of employees % | 31% | 23% | 63% |
Total value of public sale
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.